Home/Filings/4/0001127602-12-030974
4//SEC Filing

CLAYPOOL WILLIAM D MD 4

Accession 0001127602-12-030974

CIK 0000946840other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:30 PM ET

Size

13.2 KB

Accession

0001127602-12-030974

Insider Transaction Report

Form 4
Period: 2012-11-13
Transactions
  • Exercise/Conversion

    Common Stock

    2012-11-13$9.15/sh+10,000$91,50064,500 total
  • Sale

    Common Stock

    2012-11-13$24.84/sh10,000$248,42654,500 total
  • Exercise/Conversion

    Common Stock

    2012-11-13$5.68/sh+12,500$71,00067,000 total
  • Sale

    Common Stock

    2012-11-13$25.01/sh12,500$312,58554,500 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2012-11-1310,0000 total
    Exercise: $9.15From: 2009-02-25Exp: 2018-02-25Common Stock (10,000 underlying)
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2012-11-1312,5002,500 total
    Exercise: $5.68From: 2010-02-23Exp: 2019-02-22Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $24.74 to $24.88, inclusive.
  • [F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.05, inclusive.
  • [F3]The options vest in full one year from date of grant.

Issuer

VIROPHARMA INC

CIK 0000946840

Entity typeother

Related Parties

1
  • filerCIK 0001273313

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:30 PM ET
Size
13.2 KB